Undetectable preoperative levels of serum CA19-9 correlate with improved survival in patients with resectable pancreatic adenocarcinoma

被引：0
|
作者：
Berger, AC [1 ]
Meszoely, IM [1 ]
Watson, JC [1 ]
Ross, E [1 ]
Hoffman, JP [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2003年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P106
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma
    Adam C. Berger
    Ingrid M. Meszoely
    Eric A. Ross
    James C. Watson
    John P. Hoffman
    [J]. Annals of Surgical Oncology, 2004, 11 : 644 - 649
  • [2] Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma
    Berger, AC
    Meszoely, IM
    Ross, EA
    Watson, JC
    Hoffman, JP
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (07) : 644 - 649
  • [3] Accuracy of preoperative serum CA19-9 levels in predicting the resectability of patients with pancreatic adenocarcinoma
    Ying Li
    Xiaojuan Yang
    Zhanzhan Zhang
    Xiaoning Kang
    Shanglong Liu
    [J]. Oncology and Translational Medicine, 2018, 4 (01) : 6 - 9
  • [4] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Ferrone, Cristina R.
    Finkelstein, Dianne M.
    Thayer, Sarah P.
    Muzikansky, Alona
    Fernandez-del Castillo, Carlos
    Warshaw, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2897 - 2902
  • [5] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
    Halm, Ulrich
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5610 - 5610
  • [6] Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma - Reply
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina R.
    Warshaw, Andrew L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (35) : 5611 - 5611
  • [7] Assessment of Serum Neopterin, TPS and CA19-9 Levels in Patients With Pancreatic Adenocarcinoma
    Talar-Wojnarowska, R.
    Gasiorowska, A.
    Olakowski, M.
    Lekstan, A.
    Lampe, P.
    Smolarz, B.
    Romanowicz-Makowska, H.
    Kulig, A.
    Malecka-Panas, E.
    [J]. PANCREAS, 2009, 38 (08) : 1054 - 1055
  • [8] Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim, Young Choon
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Shin, Jun Ho
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1869 - 1875
  • [9] Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma
    Shultz, David B.
    Chan, Cato
    Shaffer, Jenny L.
    Kunz, Pamela L.
    Koong, Albert C.
    Chang, Daniel T.
    [J]. PANCREAS, 2014, 43 (05) : 777 - 783
  • [10] Serum CA 19-9 as Predictor in Preoperative Parameters for Resectable Pancreatic Adenocarcinoma
    Itakura, J.
    Watanabe, M.
    Hosomura, N.
    Amemiya, H.
    Kawaida, H.
    Okamoto, H.
    Kohno, H.
    Ichikawa, D.
    [J]. PANCREAS, 2018, 47 (10) : 1395 - 1395
12345